Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

TIL

Instil Bio, Inc.

Biological Products, (No Diagnostic Substances) · SIC 2836CIK 1789769Held by 1 tracked managerEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
—
Net Income FY2025
$(71.0M)
EPS (Basic, as reported)
$-10.70
Net Margin FY2025
—
ROE FY2025
-62.7%
Total Equity
$114.0M
Shares Out
7M
Business description

Instil Bio, Inc. — Biological Products, (No Diagnostic Substances). Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2020–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 0 → 0
Fiscal yearFY2020⚑FY2021FY2022⚑FY2023FY2024FY2025
Revenue00————
Research & development(19)(107)(141)(40)——
General & administrative(14)(48)(62)(48)(44)(27)
Total operating expenses(34)(156)(226)(159)(74)(79)
Operating income(34)(156)(226)(159)(74)(79)
Interest expense—0(2)(5)(9)(6)
Other income (expense), net(4)(1)(1)(1)(3)0
Pre-tax income(38)(157)(225)(156)(74)(71)
Income tax expense00(2)0—0
Net income(38)(157)(223)(156)(74)(71)
EPS — basic($2.36)($1.48)($1.72)($24.00)($11.39)($10.70)
EPS — diluted($2.36)($1.48)($1.72)($24.00)($11.39)($10.70)
Shares outstanding — basic (M)16106130777
Shares outstanding — diluted (M)16106130777
  • ⚑ Weighted-average shares changed ×6.63 between FY2020 and FY2021 — likely a stock split. Per-share figures on either side are as reported and not adjusted.
  • ⚑ Weighted-average shares changed ÷20.00 between FY2022 and FY2023 — likely a reverse split. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.